Independent, investigator-led clinical trial site in Orange City, FL. 30+ years of Phase I to IV experience for pharmaceutical and biotech sponsors, and medical care at no cost for participants.
If you live with diabetes, COPD, asthma, depression, obesity, or other conditions, you may qualify for an active clinical trial. Study care is free, and participants are compensated for time and travel.
30+ years of investigator-led research, a dedicated 9-bed Phase I unit, in-house regulatory, and a certified sample lab, staffed by a bilingual team that serves a diverse Central Florida population.
Each study is IRB-approved, investigator-led, and conducted at our Orange City, FL site. Study care and investigational medication are provided at no cost.
Evaluating a new investigational therapy for adults with Type 2 Diabetes and obesity, measuring weight loss, metabolic health, and glycemic control.
See eligibility & enroll →
Testing Depemokimab, an investigational long-acting anti-IL-5 therapy, to reduce exacerbations in adults with moderate-to-severe COPD.
See eligibility & enroll →
Evaluating Vosoritide, an investigational therapy designed to support bone growth and improve height outcomes in children with Idiopathic Short Stature.
See eligibility & enroll →
Testing Brenipatide alongside standard antidepressant therapy to delay or prevent relapse in adults currently in remission from MDD.
See eligibility & enroll →
Clinical research evaluating weight management for adults living with obesity who do not have a diabetes diagnosis.
See eligibility & enroll →A Phase 3 study (VESPER-5) of an investigational ultra-long-acting GLP-1 receptor agonist for adults with overweight or obesity and Type 2 Diabetes.
See eligibility & enroll →An investigational treatment study (AMAZE 8) for adults living with Type 2 Diabetes and overweight or obesity.
See eligibility & enroll →A clinical research study of an investigational treatment for adults with tardive dyskinesia, involuntary, repetitive movements often linked to long-term use of certain psychiatric medications.
See eligibility & enroll →A Phase 4, open-label study of valbenazine for adults with tardive dyskinesia who remain symptomatic on deutetrabenazine or after stopping a prior VMAT2 inhibitor.
See eligibility & enroll →Submit the short form or call us. A study coordinator reviews basic eligibility and calls you within one business day.
If the study looks like a fit, we schedule a screening visit at no cost: vitals, labs, and informed consent. You can opt out at any step.
If you enroll, you receive the investigational therapy on the study schedule. Study medication, labs, and visits are always free.
You are monitored throughout, with direct access to your study team. Compensation for time and travel is paid on the protocol schedule.
Optimal Research Sites has conducted Phase I through Phase IV studies across endocrinology, pulmonology, psychiatry, and cardiovascular medicine since 1994. Our team has watched the field evolve, and stayed current because our work is always about the next protocol.
We sit at the intersection of Orlando International and Sanford International airports, in the heart of the Central Florida medical corridor. That means rapid sponsor access and a large, diverse participant pool that most single-site locations cannot match.
Our Orange City location pairs a welcoming clinic front-of-house with dedicated research infrastructure: exam rooms, a certified sample lab, and a 9-bed Phase I inpatient unit just up the road in DeBary.
A study coordinator calls you within one business day. No cost. No obligation. Information stays with us.
A short drive for participants across Volusia and Seminole counties: Deltona, DeBary, DeLand, Lake Helen, Sanford, Lake Mary, Orlando, and Daytona Beach. Looking for clinical trials near you? Most of our enrolled participants live within 30 minutes of the site.
